A Relative Bioavailability Study of Bupropion XL 150 mg Tablets Under Fasting Conditions
NCT00863941
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
28
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
Abrika Bupropion 150 mg XL Tablet, single dose
DRUG:
Wellbutrin XL® 150 mg Tablet, single dose
Sponsor
Actavis Inc.